Category Archives: compliance

Mapping Opportunities with the Non-Physician Prescriber

By Clark Herman | Published: April 5, 2013
They write 92% of their prescriptions without consulting a physician and are often the first provider a patient sees, and yet nurse practitioners, physician’s assistants and other non-physician prescribers (NPPs) are still somehow overlooked by pharma as an opportunity to drive sales. A GSW Worldwide report titled The non-physician prescriber will see you now points [...]
Also posted in Advertising, Marketing, Patient Communication, Sales, Strategy, healthcare, patient compliance, patient education | Tagged , , , , , , , , , , , , | Leave a comment

The First, and Last, Word on Medication Adherence: Keep Trying!

By Guest Blogger | Published: April 1, 2013
Patient adherence to medicine is the eternal puzzle for big Pharma:  what combinations of financial incentives, personalized interventions, and just good information work best to push down that stubborn 50 per cent abandonment threshold after six months of treatment?   Certainly there are plenty of new programs on the market, so Pharm Exec believes it’s time [...]
Also posted in Guest Blog, patient compliance | Tagged , , | 2 Comments

Congress, FDA Should Consider Tech Solutions for Safer Compounding

By Guest Blogger | Published: March 14, 2013
By Niels Erik Hansen Last fall’s deadly meningitis outbreak linked to contaminated steroid injections is a tragic reminder of the risk of errors inherent in manual pharmacy medication compounding. Unsanitary conditions at the Massachusetts compounding pharmacy that made the injections resulted in fungal contamination of the drugs. The resulting outbreak sickened nearly 700 people in [...]
Also posted in Guest Blog, Manufacturing, Regulatory, Safety, Technology, healthcare | Tagged , , , , | Leave a comment

Changing the DNA of Pharma Patient Adherence Programs

By Guest Blogger | Published: March 12, 2013
by Grant Corbett Epigenetics is the study of changes in human gene expression, in particular from environmental factors.  Pharma is also experiencing epigenetic change.  Human genes are formed from DNA, which are instructions much like a blueprint.  Similarly, the environment is changing pharmaceutical DNA and how brand marketing is instructed.
Also posted in E-Media, Marketing, Patient Communication, healthcare, patient compliance, patient education | Tagged , , , , , , | 3 Comments

Following Industry, OPDP Hopes to Eliminate Silos in Ad Review

By Ben Comer | Published: March 8, 2013
The Office of Prescription Drug Promotion (OPDP) is reorganizing its two primary advertising review divisions – professional and consumer – in an attempt to stay in line with the silo-breaking, multi-channel promotional output pouring in from pharma. The line between physician marketing and consumer marketing has blurred as the facets of a brand campaign – from [...]
Also posted in Advertising, E-Media, FDA, Legal, Marketing, Patient Communication, Regulatory, Sales, patient education, social media | Tagged , , , | Leave a comment